Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01822223
Other study ID # Bio-LL-001
Secondary ID
Status Completed
Phase N/A
First received February 27, 2013
Last updated September 16, 2014
Start date November 2010
Est. completion date September 2014

Study information

Verified date March 2013
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine which implant-abutment design is more likely to promote early soft-tissue healing processes and/or will enhance longitudinal peri-implant bone and soft-tissue health.


Description:

The study will assess the integrity of the peri-implant oral soft-tissue attachment to implant abutments by comparing tissue responses to a laser-ablated implant-abutment and an implant-abutment manufactured with a smooth surface.

Investigators will assess the initial post-surgical peri-implant attachment-seal and will test whether or not the tissue-abutment interface re-forms with equal integrity when the abutment is removed and replaced with a new abutment.

Data will include histological, radiographic, clinical, and subjective aesthetics to compare the effectiveness of two abutment designs. Both devices are supplied by the BioHorizons Implant Systems Inc. of Birmingham, Alabama; the abutments are analogous in design and material except the test device has a laser-ablated surface and the control abutment is smooth.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date September 2014
Est. primary completion date August 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 19 Years and older
Eligibility Inclusion Criteria:

1. At least 19 years old

2. Healthy enough to under go treatment

3. Have one or more edentulous sites that exhibit adequate natural bone and sufficient keratinized tissue

4. Demonstrated willingness to undergo study treatment and to comply with study timeline -

Exclusion Criteria:

1. Full edentulism

2. Any chronic health condition or medication that in the opinion of the investigators may adversely affect bone healing

3. Any indication of an inability to make autonomous decisions

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Dental implant-abutments
At week-8, abutments will be removed and replaced with new Laser-Lok® abutments. An inter-arm randomization will assign subjects to one of two sub-groups per treatment arm. Sub-groups 1-a & 2-a: will receive a new Laser-Lok® abutment and a soft-tissue biopsy at week-8; a force-probe clinical attachment assessment of the same site will be delayed until week-16. Sub-groups 1-b & 2-b: will receive a new Laser-Lok® abutment and a force-probe clinical attachment assessment at week-8; a biopsy harvested from the same study site will be delayed until week-16. The implants will be restored following standard technique and a final visit will occur 6 months following permanent restoration.

Locations

Country Name City State
United States University of Alabama at Birmingham School of Dentistry Birmingham Alabama

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham BioHorizons, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proliferation of Perpendicular Connective Tissue Fibers Attached to the Abutment Tissues surrounding the abutment will be harvested via a 2 mm internal-diameter soft-tissue trephine. The tissue will be placed in an appropriately labeled vial containing a fixative; a batched histological assessment, via scanning microscopy, will be performed after tissues have been collected from 100% of participants. Microscopic analysis will categorize the proliferation and nature of peri-abutment soft tissue cells, the orientation of connective tissue fibers (if present), and will identify functionally oriented perpendicular connective tissue fibers formed as an attachment to the abutment. 8 weeks post-abutment placement Yes
Secondary Grams of Force needed to disrupt tissue attachment to the abutment A force transducing periodontal probe instrument will electronically capture the grams of force needed to disrupt the attachment to the implant abutment; tissues will be probed from the gingival margin to the alveolar bone crest at 4 points around each abutment and an adjacent tooth: measurements will be captured from the mesial, buccal, distal, and lingual. 8 weeks post-abutment placement Yes
Secondary Change in millimeters of clinical attachment to the abutment A periodontal probe will be used to measure the level of clinical attachment to the abutment in millimeters. Measurements will be captured at 4 points around each abutment; mesial, buccal, distal, and lingual. 8 weeks, 12 weeks, 16 weeks, 12 months post-abutment placement Yes
Secondary Changes in millimeters of gingival recession surrounding the abutment A periodontal probe will be used to measure the depth of gingival recession surrounding the abutment in millimeters. Measurements will be captured at 4 points around each abutment; mesial, buccal, distal, and lingual. 8 weeks, 12 weeks, 16 weeks, 12 months post-abutment placement Yes
Secondary Changes in Millimeters of Osseous Support to the Implant Radiographs and image-processing software will be used to measure peri-implant linear bone height and to assess bone support over time. Implant placement, 16 weeks, 12 months post-implant placement Yes
See also
  Status Clinical Trial Phase
Recruiting NCT02880891 - Effects of Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants N/A
Completed NCT00748241 - Study to Evaluate Implant Survival Rate of Astra Tech Fixture ST in the Posterior Maxilla With One-stage Surgery and Early Loading N/A
Active, not recruiting NCT04066309 - Implant Retained Rehabilitation With Surgical and Prosthetic Digital Workflow N/A
Active, not recruiting NCT04545840 - Prospective Neodent® Zirconia System Study
Active, not recruiting NCT06034067 - Osseodensification Versus Conventional Drilling for Implant Site Preparation N/A
Active, not recruiting NCT04546269 - Fully Guided Versus Conventionally Guided Implant Placement by Dental Students N/A
Recruiting NCT02676661 - Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Disease N/A
Recruiting NCT02662361 - Evaluation of the Prevalence and Risk Factors for Patients With Peri-implant Diseaseļ¼ša Retrospective Study N/A
Completed NCT01030523 - Short Implants - An Alternative to Bone Grafting? N/A
Completed NCT00906425 - Clinical Study Comparing Submerged Versus Trans-mucosal Healing of P.004 Implants in the Anterior Mandible and Maxilla N/A
Completed NCT03252106 - Long-term Effectiveness of Contour Augmentation in Sites With Early Implant Placement N/A
Completed NCT02975674 - Evaluation of MT-12 Implant Survival and Marginal Bone Loss N/A
Completed NCT00545818 - Study Comparing OsseoSpeedā„¢ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw N/A
Completed NCT00900822 - Straumann Bone Ceramic Versus BioOss in Sinus Elevation N/A
Completed NCT04017026 - Survival and Success Rates of 6mm Implants With a Micro-rough Surface After 4.5 - 18.2 Years in Function
Active, not recruiting NCT05315414 - Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations N/A
Recruiting NCT02814149 - Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement N/A
Active, not recruiting NCT03319758 - Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall N/A
Completed NCT01842958 - Straumann Roxolid Multi-Center Study N/A
Completed NCT01821092 - Dimensional Changes of Peri-implant Facial Bone Phase 4